产品详情
Targets
Target | Value |
---|---|
VEGFR1 | IC50: 2nM |
VEGFR2 | IC50: 3nM |
VEGFR2/Flk1 | IC50: 6nM |
VEGFR3 | IC50: 6nM |
Kit | IC50: 8nM |
RET | IC50: 59nM |
PDGFR | IC50: 84nM |
FGFR | IC50: >2.8μM |
EGFR | IC50: >3μM |
Src | IC50: >3μM |
p38 | IC50: >3μM |
In vitro (25°C) | DMSO | Warmed: 88 mg/mL (154.54 mM) | |
Water | Warmed: 17 mg/mL (29.85 mM) | ||
Ethanol | Insoluble | ||
In vivo | Saline | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.56 mL | 87.81 mL | 175.62 mL |
0.5 mM | 3.51 mL | 17.56 mL | 35.12 mL |
1 mM | 1.76 mL | 8.78 mL | 17.56 mL |
5 mM | 0.35 mL | 1.76 mL | 3.51 mL |
*The above data is based on the productmolecular weight 569.4 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10608 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 569.4 |
Formula | C22H23N5O.2H3PO4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 857876-30-3 |
Synonyms | AMG-706 |
SMILES | CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C.OP(=O)(O)O.OP(=O)(O)O |
产品资料
产品标签
Product Questions
Product Questions
E7080 (Lenvatinib)
E7080 (Lenvatinib)是一种多激酶抑制剂,可同时抑制VEGFR2和VEGFR3激酶。
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
ZM 306416
ZM 306416 hydrochloride是一种VEGF受体酪氨酸激酶抑制剂,可抑制KDR(IC50 = 100 nM)和Flt(IC50 = 2 uM)酪氨酸激酶…
NVP-BAW2881
NVP-BAW2881是有效的选择性VEGFR抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),IC50 为值9 nM,具有抑制…
Linifanib (ABT-869)
Linifanib (ABT-869)是一种结构新颖的有效RTK,VEGF和PDGF抑制剂,对人内皮细胞,PDGFR-β,KDR和CSF-1R的IC50分别为0.…
Toceranib (PHA 291639, SU 11654)
Toceranib (PHA 291639,SU 11654)是一种激酶抑制剂,通过抑制KIT,血管内皮生长因子受体2和PDGFRβ同时具有抗肿瘤…